Compare MCK & CRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCK | CRH |
|---|---|---|
| Founded | 1833 | 1936 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.9B | 84.2B |
| IPO Year | 1995 | 2002 |
| Metric | MCK | CRH |
|---|---|---|
| Price | $947.29 | $99.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 14 |
| Target Price | ★ $930.23 | $137.50 |
| AVG Volume (30 Days) | 612.5K | ★ 4.6M |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | 0.35% | ★ 1.56% |
| EPS Growth | ★ 14.87 | 9.76 |
| EPS | ★ 24.73 | 5.51 |
| Revenue | ★ $112,084,000,000.00 | $37,447,000,000.00 |
| Revenue This Year | $14.97 | $7.27 |
| Revenue Next Year | $8.20 | $5.24 |
| P/E Ratio | $38.17 | ★ $18.07 |
| Revenue Growth | 3.11 | ★ 5.27 |
| 52 Week Low | $637.00 | $76.75 |
| 52 Week High | $999.00 | $131.55 |
| Indicator | MCK | CRH |
|---|---|---|
| Relative Strength Index (RSI) | 53.95 | 21.60 |
| Support Level | $796.22 | $88.97 |
| Resistance Level | $999.00 | $100.23 |
| Average True Range (ATR) | 18.27 | 3.13 |
| MACD | -7.77 | -1.89 |
| Stochastic Oscillator | 41.42 | 0.96 |
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
CRH is a global manufacturer of a range of building products used in construction projects, operating via a vertically integrated business model. The past decade has seen CRH transform into a leading building materials business, with increasing exposure to upstream building activities such as aggregates and cement. CRH's geographic footprint is mostly across developed markets. North America is CRH's largest market and accounts for 75% of EBITDA. The company is the largest producer of aggregates and asphalt in the US.